1. Biology

The primary cilium as a gatekeeper of FGFR2 function

Written by Posted on Less than 0 min read

In this issue, Nita et al. (https://doi.org/10.1083/jcb.202311030) show that the primary cilium regulates FGFR2 signalling through spatial compartmentalization, enabling selective downstream activation. Disruption of ciliary localization in disease-linked FGFR2 variants highlights the role of the cilium as a signalling gatekeeper in development and disease.

Member since

More from Admin

Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Why did some ancient animals fossilize while others vanished?

Why do some ancient animals become fossils while others disappear without a trace? A new study from the University of Lausanne, published in Nature Communications, reveals that part of the answer lies in the body itself. The research shows that an animal’s size and chemical makeup can play an important role in determining whether it’s […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Researchers are closing in on a mouse model for late-onset Alzheimer’s

Mice don’t get Alzheimer’s — and while that’s good news for mice, it’s a big problem for biomedical researchers seeking to understand the disease and test new treatments. Now, researchers at The Jackson Laboratory are working to create the first strain of mice that’s genetically susceptible to late-onset Alzheimer’s, with potentially transformative implications for dementia […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Need for standardized measurement methods in gene therapy

In a finding with implications for one of the most promising cutting-edge medical treatments, researchers evaluated several measurement techniques commonly used in gene therapy. The study determined that one of the most popular techniques was “problematic” and requires further development and standardization. In gene therapy, a person’s faulty genes are either replaced or modified to […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

First conclusive evidence that a terrestrial leech species can jump

A new study presents video evidence that at least one species of terrestrial leech can jump, behavior that scientists have debated for more than a century. Researchers from the American Museum of Natural History, Fordham University, and City University of New York (CUNY)’s Medgar Evers College published the footage and corresponding analysis today in the […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Not so selfish after all: Viruses use freeloading genes as weapons

Curious bits of DNA tucked inside genomes across all kingdoms of life historically have been disregarded since they don’t seem to have a role to play in the competition for survival. Or so researchers thought. These DNA pieces came to be known as “selfish genetic elements” because they exist, as far as scientists could tell, […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Misha lived in zoos, but the elephant’s tooth enamel helps reconstruct wildlife migrations

Teeth recovered from a beloved zoo elephant that died in 2008 are helping University of Utah geologists develop a method for tracking the movements of large herbivores across landscapes, even for animals now extinct, such as mastodons and mammoths. Outlined in recently published findings, the technique analyzes isotope ratios of the element strontium (Sr), which […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Caterpillars can detect their predators by the static electricity they emit

Caterpillars respond defensively to electric fields similar to those emitted by their natural predators, scientists at the University of Bristol have found. In the study, published today in the journal PNAS, experts showed that caterpillar hairs move in response to electric fields and are most sensitive to the frequencies that correspond to the wingbeats frequencies […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Global patterns in seed plant distribution over millions of years

Why do some plants thrive in specific regions but not in others? A study led by researchers at the University of Göttingen explores the factors shaping plant distributions and how these patterns have changed over millions of years. Analyzing nearly 270,000 seed plant species worldwide, the research highlights the roles of environmental conditions and dispersal […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Viral ‘backbone’ underlies variation in rotavirus vaccine effectiveness

Researchers have shown that differences in the entire rotavirus genome — not just its two surface proteins — affect how well vaccines work, helping to explain why some strains are more likely to infect vaccinated individuals. The study, published today as a Reviewed Preprint in eLife, is described by the editors as an important paper. […]
Written by
  1. Clinical

First-Affected person Dosed in Part 2 Scientific Examine Evaluating NBI-1070770 in Adults with Main Depressive Dysfunction

SAN DIEGO, April 3, 2024. Neurocrine Biosciences, Inc. right this moment introduced that the primary affected person has been randomized for its Part 2 scientific research to judge the efficacy, security, and tolerability of investigational compound NBI-1070770 in adults with main depressive dysfunction. NBI-1070770 is a novel, selective, and orally energetic, unfavorable allosteric modulator (NAM) […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Clinical

FDA Clears Application to Initiate Phase 1 Clinical Study of oral Immunotherapy for the Treatment of Rheumatoid Arthritis

ROCKVILLE, Md., Oct. 19, 2023. – Rise Therapeutics, a biotechnology company engaged in developing novel oral immunotherapeutics, today announced that the U.S. Food and Drug Administration (FDA) has accepted its investigational new drug (IND) application to proceed with a rheumatoid arthritis Phase 1 clinical trial for its program candidate, R-2487. This is Rise Therapeutics’ second […]
Written by
  1. Biology

ESCRT-I and PTPN23 mediate microautophagy of ubiquitylated tau aggregates

Protein aggregates are degraded by both the autophagy–lysosomal and the ubiquitin–proteasome pathways. Macroautophagy and microautophagy, two forms of the autophagy–lysosomal pathway, are widely conserved across eukaryotes. While macroautophagy has been extensively studied in the context of degradation of protein aggregates, microautophagy remains less explored. Here, we identify the UBAP1-containing ESCRT-I complex and PTPN23 as new […]
Written by
  1. Biology

Structural insights into the coupling between VCP, an essential unfoldase, and a deubiquitinase

Proteostasis involves degradation and recycling of proteins from organelles, membranes, and multiprotein complexes. These processes can depend on protein extraction and unfolding by the essential mechanoenzyme valosin-containing protein (VCP) and on ubiquitin chain remodeling by ubiquitin-specific proteases known as deubiquitinases (DUBs). How the activities of VCP and DUBs are coordinated is poorly understood. Here, we […]
Written by
  1. Biology

Ca 2+ binding to Esyt modulates membrane contact site density in Drosophila photoreceptors

Membrane contact sites (MCS) between the plasma membrane (PM) and endoplasmic reticulum (ER) regulate Ca2+ influx. However, the mechanisms by which cells modulate ER–PM MCS density are not understood, and the role of Ca2+, if any, in regulating these is unknown. We report that in Drosophila photoreceptors, MCS density is regulated by the Ca2+ channels, […]
Written by
  1. Pharmaceuticals and Drug Development

Scholar Rock Submits Biologics License Application (BLA) to the U.S. FDA for Apitegromab as a Treatment for Patients with Spinal Muscular Atrophy (SMA)

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Jan. 29, 2025– Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious… Admin Member since October 11, 2023 Loading + Follow Following
Written by
Next
No Comments
Leave a comment Cancel
Comments to: The primary cilium as a gatekeeper of FGFR2 function

Login

Welcome to Life Science News!
"Explore the Latest Discoveries and Breakthroughs in Life Science with Life Science News!"
Read Smart, Save Time
Pick all the topics you are interested in to fill your homepage with stories you'll love.
Join our community
Registration is closed.